The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Methacholine chloride 100 mg Powder for nebuliser solution

Acic Europe LimitedPA2326/001/001

Main Information

Trade NameMethacholine chloride 100 mg Powder for nebuliser solution
Active SubstancesMethacholine Chloride
Dosage FormPowder for nebuliser solution
Licence HolderAcic Europe Limited
Licence NumberPA2326/001/001

Group Information

ATC CodeV04CX Other diagnostic agents
V04CX03 methacholine


License statusAuthorised
Licence Issued12/06/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back